Pickard JG, van den Berk-Clark C, Matthieu MM. Association of Medication-Assisted Treatment and Age With Treatment Completion Among Veterans Seeking Non-VA Treatment for Opioid use Disorder at Non-Veterans Health Administration Facilities. Military medicine. 2022 Mar 28; 187(3-4):504-512.
Pro G, Hayes C, Brown CC, Goree J, Zaller N. Individual and Health Policy Factors Associated With Positive Heroin and Opioid Treatment Response: United States, 2018. American journal of public health. 2022 Feb 1; 112(S1):S66-S76.
Kramer JR, Puenpatom A, Cao Y, Yu X, El-Serag HB, Kanwal F. Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population. The American journal of drug and alcohol abuse. 2022 Jan 25; 1-9.
Townsend TN, Bohnert ASB, Merlin JS. Opioid Prescribing to Patients With Advanced Cancer: Unanswered Questions. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2022 Jan 20; 40(3):311-312.
Hayes CJ, Krebs EE, Li C, Brown J, Hudson T, Martin BC. Association between discontinuing chronic opioid therapy and newly diagnosed substance use disorders, accidents, self-inflicted injuries and drug overdoses within the prescribers' health care system: a retrospective cohort study. Addiction (Abingdon, England). 2022 Apr 1; 117(4):946-968.
Kelley AT, Dungan MT, Gordon AJ. Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19. Journal of addiction medicine. 2021 Sep 1; 15(5):439-440.
Lei L, Bynum JP, Maust DT. Opioid and CNS-Depressant Medication Prescribing among Older Adults Enrolled in Medicare Advantage Versus Fee-for-Service Medicare. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2022 Feb 1; 30(2):249-255.
Chua KP, Brummett CM, Ng S, Bohnert ASB. Association Between Receipt of Overlapping Opioid and Benzodiazepine Prescriptions From Multiple Prescribers and Overdose Risk. JAMA Network Open. 2021 Aug 2; 4(8):e2120353.
Magaletta PR, Morasco BJ. Perspectives on opioid misuse from public service psychology: An introduction. Psychological Services. 2021 Aug 1; 18(3):285-286.
Rao IJ, Humphreys K, Brandeau ML. Effectiveness of Policies for Addressing the US Opioid Epidemic: A Model-Based Analysis from the Stanford-Lancet Commission on the North American Opioid Crisis. Lancet Regional Health. Americas. 2021 Nov 1; 3.
Hayes CJ, Krebs EE, Brown J, Li C, Hudson T, Martin BC. Association Between Pain Intensity and Discontinuing Opioid Therapy or Transitioning to Intermittent Opioid Therapy After Initial Long-Term Opioid Therapy: A Retrospective Cohort Study. The journal of pain. 2021 Dec 1; 22(12):1709-1721.
Khouja T, Tadrous M, Matusiak L, Suda K. Opioid Prescribing in United States Health Systems, 2015 to 2019. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2021 Sep 1; 24(9):1279-1284.
Robles M, Mortazavi L, Vannerson J, Matthias MS. How a Medication for Opioid Use Disorder Curriculum Translates into Experiences and Internal Medicine Residents' Understanding of Patients with Opioid Use Disorder. Teaching and learning in medicine. 2021 May 11; 1-8.
DeRonne BM, Wong KR, Schultz E, Jones E, Krebs EE. Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2021 Feb 8; 78(4):354-359.
Priest KC, McCarty D, Lovejoy TI. Expanding Access to Medications for Opioid Use Disorder: Program and Policy Approaches from Outside the Veterans Health Administration. Journal of general internal medicine. 2020 Dec 1; 35(Suppl 3):886-890.
Koffel E, DeRonne B, Hawkins EJ. Co-prescribing of Opioids with Benzodiazepines and Other Hypnotics for Chronic Pain and Insomnia: Trends and Health Outcomes. Pain medicine (Malden, Mass.). 2020 Oct 1; 21(10):2055-2059.
Rogal SS. Opioid Avoidance After Liver Transplantation: The Ever-Shifting Pain Management Paradigm. [Editorial]. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2020 Oct 1; 26(10):1221-1223.
Hser YI, Mooney LJ. Integrating Telemedicine for Medication Treatment for Opioid Use Disorder in Rural Primary Care: Beyond the COVID Pandemic. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2021 Jan 1; 37(1):246-248.
Khatri UG, Perrone J. Opioid Use Disorder and COVID-19: Crashing of the Crises. Journal of addiction medicine. 2020 Jul 1; 14(4):e6-e7.
Caulkins JP, Humphreys KN. Preventing opioid use and addiction: New thinking and the latest evidence. The Opioid Crisis In America: A paper series from the Foreign Policy and Global Economy & Development programs at Brookings [Internet]. 2020 Jun 22: Available from: Washington, DC.
Carlson KF. 219 Trends in the Prevalence of Concurrent Non-VA Opioid and Benzodiazepine Prescriptions among Veterans Receiving Long-term Opioid Therapy from the VA. [Abstract]. Injury Prevention : Journal of The International Society For Child and Adolescent Injury Prevention. 2020 May 5; 26(Suppl 1):A38.
Minegishi T, Strombotne KL, Frakt AB, Barr K. Preliminary findings of the evaluation of the Stratification Tool for Opioid Risk Mitigation, focused on Serious Adverse Events, mortality outcomes in the high risk (1-5% risk) dashboard patients: Briefing before the Program Evaluation and Resource Center, VA Office of Mental Health Operations (Jodie Trafton, Elizabeth Olivia, and Friedhelm Sandbrink); 2020 May 1; Telephone Briefing.
Becker WC, Frank JW, Edens EL. Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series. Annals of internal medicine. 2020 Jul 7; 173(1):70-71.
Minegishi T, Strombotne KL, Frakt AB, Barr K. Preliminary findings of the policy analysis portion of the evaluation of the Stratification Tool for Opioid Risk Mitigation: Briefing before the Program Evaluation and Resource Center, VA Office of Mental Health Operations (Jody Trafton, Director); 2020 Apr 7; Telephone Briefing.
Becker WC, Fiellin DA. When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis. [Editorial]. Annals of internal medicine. 2020 Jul 7; 173(1):59-60.
Acharya M, Chopra D, Hayes CJ, Teeter B, Martin BC. Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2020 Apr 1; 23(4):451-460.
Kiang MV, Humphreys K, Cullen MR, Basu S. Opioid prescribing patterns among medical providers in the United States, 2003-17: retrospective, observational study. BMJ (Clinical research ed.). 2020 Jan 29; 368:l6968.
Hayes CJ, Krebs EE, Hudson T, Brown J, Li C, Martin BC. Impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdoses: a retrospective cohort study. Addiction (Abingdon, England). 2020 Jun 1; 115(6):1098-1112.
Humphreys KN, Caulkins JP, Felbab-Brown V. Order from Chaos: What the US and Canada Can Learn From Other Countries to Combat the Opioid Crisis. Brookings Institution [Internet]. 2020 Jan 13:Order From Chaos(Blog):1. Available from: Washington, DC.
Frank JW, Binswanger IA. Commentary on Rhee & Rosenheck (2019): Buprenorphine prescribing for opioid use disorder in medical practice - can office-based out-patient care address the opiate crisis in the United States?. [Letter to the Editor]. Addiction (Abingdon, England). 2020 Apr 1; 115(4):786-787.
Cochran G, Bruneau J, Cox N, Gordon AJ. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. Substance Abuse. 2020 Jan 1; 41(3):269-274.
Seal KH, Rife T, Li Y, Gibson C, Tighe J. Opioid Reduction and Risk Mitigation in VA Primary Care: Outcomes from the Integrated Pain Team Initiative. Journal of general internal medicine. 2020 Apr 1; 35(4):1238-1244.
Cuellar MF, Humphreys KN. The Political Economy of the Opioid Epidemic. Yale Law & Policy Review. 2020 Jan 5; 38(1):SSRN: https://ssrn.com/abstract=3503149.
Turvey CL, Lund BC, Jones D, Arndt S. Community Treatment for Opioid Use Disorders in Urban and Rural Veterans. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2020 Mar 1; 36(2):167-176.
Andrews CM, Humphreys K, Grogan CM. How Medicaid work requirements could exacerbate the opioid epidemic. The American journal of drug and alcohol abuse. 2019 Dec 4; 46(1):1-3.
Chen JA. Capsule Commentary on Sullivan et al., Primary Care Opioid Taper Plans Are Associated with Sustained Opioid Dose Reduction. Journal of general internal medicine. 2020 Mar 1; 35(3):980.
Krause JS, Dismuke-Greer CE, Reed KS, Li C. Employment status, hours working, and gainful earnings after spinal cord injury: relationship with pain, prescription medications for pain, and nonprescription opioid use. Spinal Cord. 2020 Mar 1; 58(3):275-283.
Maloy PE, Iacocca MO, Morasco BJ. CE: Implementing Guidelines for Treating Chronic Pain with Prescription Opioids. The American Journal of Nursing. 2019 Nov 1; 119(11):22-29.
Gibson CJ, Li Y, Huang AJ, Rife T, Seal KH. Menopausal Symptoms and Higher Risk Opioid Prescribing in a National Sample of Women Veterans with Chronic Pain. Journal of general internal medicine. 2019 Oct 1; 34(10):2159-2166.
Evans EA, Yoo C, Huang D, Saxon AJ, Hser YI. Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2?years: Results from a multisite randomized trial of adults with opioid use disorder. Journal of substance abuse treatment. 2019 Nov 1; 106:19-28.
Hawkins EJ, Goldberg SB, Malte CA, Saxon AJ. New Coprescription of Opioids and Benzodiazepines and Mortality Among Veterans Affairs Patients With Posttraumatic Stress Disorder. The Journal of clinical psychiatry. 2019 Jul 9; 80(4).
Humphreys KN. We can't fight opioids by controlling demand alone. Washington Post. 2019 Jul 5.
Andrews CM, Humphreys K. Investing in Medicaid to End the Opioid Epidemic. Psychiatric services (Washington, D.C.). 2019 Jul 1; 70(7):537.
Gonzales-Castaneda R, Mooney LJ, Rawson RA. Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks, Offering a Public Health Perspective-A Commentary on Camenga et al. Journal of studies on alcohol and drugs. 2019 Jul 1; 80(4):403-405.
Vest N, Humphreys KN. Do We Know Enough to Prescribe Opioid-Agonist Therapies to Adolescents With Problematic Opioid Use? A Commentary on Camenga et al. (2019). Journal of studies on alcohol and drugs. 2019 Jul 1; 80(4):406-407.
Matthias MS, Talib TL, Huffman MA. Managing Chronic Pain in an Opioid Crisis: What Is the Role of Shared Decision-Making?. Health communication. 2020 Sep 1; 35(10):1239-1247.
Shover CL, Davis CS, Gordon SC, Humphreys K. Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proceedings of the National Academy of Sciences of the United States of America. 2019 Jun 25; 116(26):12624-12626.
Young SG, Hayes CJ, Aram J, Tait MA. Doctor hopping and doctor shopping for prescription opioids associated with increased odds of high-risk use. Pharmacoepidemiology and drug safety. 2019 Aug 1; 28(8):1117-1124.
Lagisetty PA, Bohnert A. Role of an Accurate Treatment Locator and Cash-Only Practices in Access to Buprenorphine for Opioid Use Disorders. [Editorial]. Annals of internal medicine. 2019 Jul 2; 171(1):58-59.
Adams RS, Larson MJ, Meerwijk EL, Williams TV, Harris AHS. Postdeployment Polytrauma Diagnoses Among Soldiers and Veterans Using the Veterans Health Affairs Polytrauma System of Care and Receipt of Opioids, Nonpharmacologic, and Mental Health Treatments. The Journal of head trauma rehabilitation. 2019 May 1; 34(3):167-175.
Morrow DJ, Fischer EP, Walder AM, Jubran NI. Nonopioid Alternatives to Addressing Pain Intensity: A Retrospective Look at 2 Noninvasive Pain Treatment Devices. Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 2019 Apr 1; 36(4):181-187.
Humphreys KN. Opioids, cannabis, and vaping: Using science to protect public health: Briefing before the Joint Hearing of Senate and General Assembly Health and Human Services Committee, State of Rhode Island; 2019 Mar 1; Providence, Rhode Island.
Shah A, Hayes CJ, Lakkad M, Martin BC. Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use. Journal of general internal medicine. 2019 Aug 1; 34(8):1419-1426.
Morasco BJ, Dobscha SK, Hyde S, Mitchell SH. Exploratory study examining associations between prescription opioid dose and delay discounting in patients with chronic pain. Journal of opioid management. 2019 Jan 1; 15(1):19-25.
Herzig SJ, Mosher HJ, Calcaterra SL, Nuckols TK. Reply to "In Reference to 'Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement from the Society of Hospital Medicine'". Journal of hospital medicine. 2018 Sep 1; 13(10):728.
Bohnert ASB, Guy GP, Losby JL. Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention's 2016 Opioid Guideline. Annals of internal medicine. 2018 Sep 18; 169(6):367-375.
Kertesz SG, Gordon AJ. A crisis of opioids and the limits of prescription control: United States. Addiction (Abingdon, England). 2019 Jan 1; 114(1):169-180.
Pitt AL, Humphreys K, Brandeau ML. Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic. American journal of public health. 2018 Oct 1; 108(10):1394-1400.
Hayes CJ, Payakachat N, Li C. Evaluation of opioid use among patients with back disorders and arthritis. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2018 Nov 1; 27(11):3021-3035.
Minegishi T, Garrido MM, Pizer SD, Frakt AB. Effectiveness of policy and risk targeting for opioid-related risk mitigation: a randomised programme evaluation with stepped-wedge design. BMJ open. 2018 Jun 27; 8(6):e020097.
Koppen L, Suda KJ, Rowan S, McGregor J, Evans CT. Dentists' prescribing of antibiotics and opioids to Medicare Part D beneficiaries: Medications of high impact to public health. Journal of the American Dental Association (1939). 2018 Aug 1; 149(8):721-730.
Hawkins EJ. Opioid and Benzodiazepine Co-prescribing and Mortality among VA Patients with Posttraumatic Stress Disorder. HSR&D CyberSeminars [Cyberseminar]. HSR&D. 2018 Jun 11.
Darnall BD, Humphreys KN. An experimental method for assessing whether marijuana use reduces opioid use in patients with chronic pain. [Letter to the Editor]. Addiction (Abingdon, England). 2018 Aug 1; 113(8):1552-1553.
Lewis ET. Data-Based Case Reviews of Patients with Opioid Related Risk Factors as a Tool to Prevent Overdose and Suicide. SoSP (Suicide Prevention) [Cyberseminar]. HSR&D. 2018 Jun 4.
Butler JM, Becker WC, Humphreys K. Big Data and the Opioid Crisis: Balancing Patient Privacy with Public Health. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics. 2018 Jun 1; 46(2):440-453.
Minegishi T, Frakt A. Reducing Long-term Opioid Use in the Veterans Health Administration. [Editorial]. Journal of general internal medicine. 2018 Jun 1; 33(6):781-782.
Ashrafioun L, Allen KD, Pigeon WR. Utilization of complementary and integrative health services and opioid therapy by patients receiving Veterans Health Administration pain care. Complementary therapies in medicine. 2018 Aug 1; 39:8-13.
Frank JW, Gilmartin HM. Pain Management and Opioid Safety. https://www.hsrd.research.va.gov/news/podcasts/listen.cfm?ID=28; 2018 May 4. Available from: https://www.hsrd.research.va.gov/news/podcasts/listen.cfm?ID=28.
Alzeer AH, Jones J, Bair MJ. Review of Factors, Methods, and Outcome Definition in Designing Opioid Abuse Predictive Models. Pain medicine (Malden, Mass.). 2018 May 1; 19(5):997-1009.
Carey EP, Nolan C, Kerns RD, Ho PM, Frank JW. Association Between Facility-Level Utilization of Non-pharmacologic Chronic Pain Treatment and Subsequent Initiation of Long-Term Opioid Therapy. Journal of general internal medicine. 2018 May 1; 33(Suppl 1):38-45.
Matthias MS, Donaldson MT, Jensen AC, Krebs EE. "I Was a Little Surprised": Qualitative Insights From Patients Enrolled in a 12-Month Trial Comparing Opioids With Nonopioid Medications for Chronic Musculoskeletal Pain. The journal of pain : official journal of the American Pain Society. 2018 Sep 1; 19(9):1082-1090.
Mosher HJ, Richardson KK, Lund BC. Sedative Prescriptions Are Common at Opioid Initiation: An Observational Study in the Veterans Health Administration. Pain medicine (Malden, Mass.). 2018 Apr 1; 19(4):788-792.
Lembke A, Humphreys K. The Opioid Epidemic as a Watershed Moment for Physician Training in Addiction Medicine. Academic Psychiatry : The Journal of The American Association of Directors of Psychiatric Residency Training and The Association For Academic Psychiatry. 2018 Apr 1; 42(2):269-272.
Hadlandsmyth K, Mosher H, Vander Weg MW, Lund BC. Decline in Prescription Opioids Attributable to Decreases in Long-Term Use: A Retrospective Study in the Veterans Health Administration 2010-2016. Journal of general internal medicine. 2018 Jun 1; 33(6):818-824.
Humphreys K. A public health approach to opioid addiction in North America - Author's reply. Lancet (London, England). 2018 Jan 20; 391(10117):202.
Tessier CD. Using Opioids Safely After Surgery. Consumer Reports (Choosing Wisely) [Internet]. 2017 Dec 1: Available from: http://www.choosingwisely.org/wp-content/uploads/2018/02/Using-Opioids-Safely-After-Surgery-AUA.pdf.
Frakt AB. Where Is the Prevention in the President's Opioid Report? The New York Times. 2017 Nov 13: The Upshot: A3.
Taylor SL. Addressing America's Opioid Problem: The Need for Evidence-Based Strategies: Briefing before the Senator and Congressional staffers, organized by PCORI and Anthem Blue Cross; 2017 Sep 19; Wash DC.
Frakt AB. A Helpful Tool to Combat the Opioid Crisis. New York Times. 2017 Sep 11: The Upshot: The New Health Care.
Gerlach LB, Olfson M, Kales HC, Maust DT. Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States. Journal of the American Geriatrics Society. 2017 Sep 1; 65(9):2052-2056.
Ecker AH, Hundt N. Posttraumatic stress disorder in opioid agonist therapy: A review. Psychological trauma : theory, research, practice and policy. 2018 Nov 1; 10(6):636-642.
Humphreys K. Avoiding globalisation of the prescription opioid epidemic. Lancet. 2017 Jul 29; 390(10093):437-439.
Becker W, Lovejoy TI. Opioid dose reduction in patients prescribed long-term opioid therapy for chronic pain. HSR&D Career Development Award Enhancement Initiative [Cyberseminar]. VA HSR&D. 2017 Jul 26.
Becker WC, Lovejoy T. Opioid Dose Reduction in Patients Prescribed Long-Term Opioid Therapy for Chronic Pain. Career Development Award Series [Cyberseminar]. HSR&D. 2017 Jul 26.
Hanks D, Hecht MI, Auffrey RR, Hawkins EJ. Podcast-10: Live from the Meeting: Opioid Co-Prescribing and PTSD Mortality. 2017 Jul 20. 1 (10). Available from: https://www.hsrd.research.va.gov/news/podcasts/default.cfm.
Lagisetty P, Bohnert A. Web Exclusives. Annals for Hospitalists Inpatient Notes - The Opioid Epidemic-What's a Hospitalist to Do?. Annals of internal medicine. 2017 Jul 18; 167(2):HO2-HO3.
Cochran G, Rosen D, McCarthy RM, Engel RJ. Risk Factors for Symptoms of Prescription Opioid Misuse: Do Older Adults Differ from Younger Adult Patients?. Journal of gerontological social work. 2017 Aug 1; 60(6-7):443-457.
Midboe AM. Academic Detailing for Opioid Prescribing in VISN 21:Results from a Qualitative Rapid Analysis: Briefing before the National Pharmacy Benefits Management Advisory Board; 2017 May 2; San Diego, CA.
Bossi KE. HSR&D e-Pub Briefs-3: Summaries of select journal articles published by HSR&D investigators on Acute Pain, Chronic Pain, C. Diff Infection, Hypertension, and Opioids. 2017 May 1; 9(3).
Gordon AJ, Harding JD. From education to practice: Addressing opioid misuse through health care provider training: A special issue of Substance Abuse journal. Substance Abuse. 2017 Apr 1; 38(2):119-121.
Lovejoy TI, Demidenko MI, Morasco BJ, Meath T, Dobscha SK. Suicidal ideation and behaviors following clinician-initiated prescription opioid discontinuation among long-term opioid users. [Abstract]. The journal of pain : official journal of the American Pain Society. 2017 Apr 1; 18(4):S36.
Brennan PL, Del Re AC, Henderson PT, Trafton JA. Healthcare system-wide implementation of opioid-safety guideline recommendations: the case of urine drug screening and opioid-patient suicide- and overdose-related events in the Veterans Health Administration. Translational behavioral medicine. 2016 Dec 1; 6(4):605-612.
Roberts AW, Gellad WF, Skinner AC. Lock-In Programs and the Opioid Epidemic: A Call for Evidence. [Editorial]. American journal of public health. 2016 Nov 1; 106(11):1918-1919.
White W, Galanter M, Humphreys KN, Kelly JF. The Paucity of Attention to Narcotics Anonymous in Current Public, Professional, and Policy Responses to Rising Opioid Addiction. Alcoholism Treatment Quarterly. 2016 Oct 5; 34(4):437-462.
Midboe AM. Academic Detailing for Opioid Prescribing in VISN 21: Translating Lessons Learned. Presented at: VA Center for Innovation to Implementation (Ci2i) Annual Steering Committee Meeting; 2016 Aug 30; Menlo Park, CA.
Lagisetty P, Heisler M, Bohnert A. Re-purposing anticoagulation clinics: expanding access to opioid agonist therapy in primary care settings. Addiction (Abingdon, England). 2017 Mar 1; 112(3):384-385.
Midboe AM. Academic Detailing for Opioid Prescribing in VISN 21: Results from a Qualitative Rapid Analysis: Briefing before the National Pharmacy Benefits Management (PBM); 2016 Aug 23; Teleconference.
Gellad WF. University of Pittsburgh Efforts to Address the Opioid Epidemic: Briefing before the Assistant Secretary for Financial Resources, United States Department of Health and Human Services; 2016 Aug 9; Pittsburgh, PA.
Hanks D. In Progress-2: Improving the Safety of Prescription Opioid Use among Veterans. 2016 Aug 3; 1(2).
Krebs EE. ACP representative to the AMA Task Force to reduce Opioid Abuse and spoke on a panel at the AMA Delegates meeting. What practical tools exist-or are needed-to help physicians better manage patients with chronic non-cancer pain? Presented at: American Medical Association Annual Meeting; 2016 Jun 13; Chicago, IL.
Mosher HJ, Richardson KK, Lund BC. The One Year Treatment Course of New Opioid Recipients in Veterans Health Administration. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2016 May 11; Hollywood, FL.
Martin BC, Hayes C, Austen M, Hudson T. Author response to "Impact of survival bias on opioid-related outcomes when using death as an exclusion criterion". [Letter to the Editor]. Pharmacoepidemiology and drug safety. 2016 Apr 1; 25(4):477-8.
Timko C, Gupta S, Schultz N, Harris AH. Veterans' Service Utilization Patterns After Alcohol and Opioid Detoxification in VHA Care. Psychiatric services (Washington, D.C.). 2016 Apr 1; 67(4):460-4.
Tobin DG, Andrews R, Becker WC. Prescribing opioids in primary care: Safely starting, monitoring, and stopping. Cleveland Clinic journal of medicine. 2016 Mar 1; 83(3):207-15.
Krebs EE, Gravely AA, Jensen AC, Bair M, Kroenke K. Expectations and analgesic preferences among participants in a 12-month trial comparing opioid versus non-opioid analgesics for chronic pain. Poster session presented at: American Academy of Pain Medicine Annual Meeting; 2016 Feb 20; Palm Springs, CA.
Krebs EE, Kroenke K, Bair MJ, Jensen A. Expectations and Analgesic Preferences Among Participants in a 12-month Trial Comparing Opioid Versus Non-Opioid Analgesics for Chronic Pain. Presented at: American Academy of Pain Medicine Annual Meeting; 2016 Feb 18; Palm Springs, CA.
Ilgen MA. High opioid doses could be marker for suicide risk. VA Research Currents. 2016 Feb 3.
Becker WC, Merlin JS, Manhapra A, Edens EL. Management of patients with issues related to opioid safety, efficacy and/or misuse: a case series from an integrated, interdisciplinary clinic. Addiction science & clinical practice. 2016 Jan 28; 11(1):3.
Fassio V, Aspinall SL, Cunningham J, Zhao X. Trends in Non-Steroidal Anti-Inflammatory Drug Prescriptions Before and After an Opioid Safety Initiative in the Veterans Health Administration. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; 2015 Dec 6; New Orleans, LA.
Bachhuber MA, Roberts CB, Metraux S, Montgomery AE. Screening for homelessness among individuals initiating medication-assisted treatment for opioid use disorder in the Veterans Health Administration. Journal of opioid management. 2015 Nov 1; 11(6):459-62.
Finlay AK, Bowe T, Sox-Harris AH. Changes in receipt of pharmacotherapy for opioid use disorder among veterans from fiscal years 2012-2013. Paper presented at: Addiction Health Services Research Conference; 2015 Oct 15; Marina del Rey, CA.
Hawkins EJ, Malte CA, Grossbard JR, Saxon AJ. Prevalence and Trends of Concurrent Opioid Analgesic and Benzodiazepine Use Among Veterans Affairs Patients with Post-traumatic Stress Disorder, 2003-2011. Pain medicine (Malden, Mass.). 2015 Oct 1; 16(10):1943-54.
Nosyk B, Min JE, Evans E, Li L, Liu L, Lima VD, Wood E, Montaner JS. The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015 Oct 1; 61(7):1157-65.
Trafton JA, Henderson P, Paik M, Tavakoli S, Bowe T, Oliver J, Midboe AM, Lewis ET. VA Opioid Therapy Clinical Practice Guideline Adherence Report: Customizable intranet-based report of facility-level adherence to guideline recommended care practice to improve the safety and efficacy of opioid prescribing for pain. 2015 Oct 1. Available from: http://vssc.med.va.gov/VSSCAgreements/Default.aspx?locn=http%3A//vssc.med.va.gov/uat.asp..
Hawkins EJ, Malte CA, Saxon AJ, Sayre G. Evaluating a Medication Alert to Reduce Concurrent Opioid and Benzodiazepine Use at a Single VA Health Care System. Paper presented at: Society for Implementation Research Collaboration Biennial Conference on Advancing Efficient Methodologies Through Community Partnerships and Team Science; 2015 Sep 10; Seattle, WA.
Gordon AJ, Oliva EM, Wells DL, Harding JD. Opioid overdose education and naloxone distribution to prevent opioid overdose mortality [Buprenorphine Initiative in the VA Monthly Webinar Series]. [Cyberseminar]. 2015 Sep 8.
Bair MJ, Bohnert AS. Overdoses in Patients on Opioids: Risks Associated with Mental Health Conditions and Their Treatment. [Editorial]. Journal of general internal medicine. 2015 Aug 1; 30(8):1051-3.
Broyles LM. Getting evidence into real-life practice and systems of care: what SBIRT, opioid agonist treatment, and integrated care look like in the VA. Presented at: Institute for Research, Education, and Training in Addictions Annual Meeting; 2015 Jul 10; Pittsburgh, PA.
Hawkins EJ, Malte CA, Grossbard JR, Saxon AJ. Prevalence and Trends of Concurrent Opioid Analgesic and Benzodiazepine Use Among Veterans Affairs Patients with PTSD 2003-2011. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 10; Philadelphia, PA.
Bohnert AS, Levine DA, Ganoczy D, Blow FC. Factors associated with opioid overdose death among VHA patients age 50 and older prescribed opioids. Poster session presented at: VA HSR&D / QUERI National Meeting; 2015 Jul 9; Philadelphia, PA.
Oliva EM. Saving Veterans Lives through Implementation of Opioid Overdose Education and Naloxone Distribution (OEND). Presented at a Public Hearing on Exploring Naloxone Uptake and Use. Federal Drug Administration Center for Drug Evaluation and Research; 2015 Jul 1; Silver Spring, MD. 2015 Jul 1.
Marcus SC, Olfson M, Amos T, Durkin M. Patient characteristics and acute care service use of Medicare beneficiaries meeting opioid overutilization criteria. Poster session presented at: AcademyHealth Annual Research Meeting; 2015 Jun 15; Minneapolis, MN.
Maughan B, Bachhuber MA, Mitra N, Starrels J. Prescription monitoring program implementation was not associated with changes in emergency department visits involving opioid analgesics. Poster session presented at: AcademyHealth Annual Research Meeting; 2015 Jun 15; Minneapolis, MN.
Krebs EE, Kroenke K, Wu J, Bair MJ, Yu Z. Baseline opioid use as a predictor of telecare collaborative pain management outcomes. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2015 Apr 23; Toronto, Canada.
Bohnert AS. Preventing prescription opioid overdoses: Changing prescribing practices and patients’ risky opioid use. Paper presented at: VA VISN 11 Opioid Safety Initiative and Pain Management Seminar; 2015 Apr 22; Fort Wayne, IN.
Bohnert AS. Preventing prescription opioid overdoses: Changing prescribing practices and patients’ risky opioid use. Paper presented at: VA Palo Alto Center for Innovation to Implementation Seminar Series; 2015 Apr 20; Palo Alto, CA.
Ilgen MA. Opioid dose and risk of suicide mortality. Paper presented at: American Association of Suicidology Annual Conference; 2015 Apr 17; Atlanta, GA.
Bohnert AS. Preventing prescription opioid overdoses: Changing prescribing practices and patients’ risky opioid use. Paper presented at: Kaiser Permanente Division of Research Annual Meeting; 2015 Apr 16; San Francisco, CA.
Bachhuber MA, Saloner B, Barry CL. What ecologic analyses cannot tell us about medical marijuana legalization and opioid pain medication mortality--reply. JAMA internal medicine. 2015 Apr 1; 175(4):656-7.
Finney JW, Humphreys K, Harris AH. What ecologic analyses cannot tell us about medical marijuana legalization and opioid pain medication mortality. [Letter to the Editor]. JAMA internal medicine. 2015 Apr 1; 175(4):655-6.
Bohnert AS. Prescription drug abuse, overdose, and responsible opioid prescribing. Paper presented at: Oakland County Health Division, Prescription Drug Abuse and Overdose Prevention Collaborative Meeting; 2015 Mar 20; Pontiac, MI.
Finlay AK, Binswanger I, Frayne SM, Harris A. Receipt of pharmacotherapy for opioid use disorder: Comparing justice-involved Veterans with other Veterans. Presented at: Academic and Health Policy Conference on Correctional Health; 2015 Mar 19; Boston, MA.
Oliva EM. Implementing Opioid Overdose Education and Naloxone Distribution (OEND) to Prevent Opioid Overdose Mortality. Presented at: VA / Department of Defense Suicide Prevention Annual Conference; 2015 Jan 28; Dallas, TX.
Good CB. VA response to FDA abuse-deterrent opioid medications initiative [invited presentation]. Presented at: Development and Regulation of Abuse-Deterrent Opioid Medications FDA Public Meeting; 2014 Oct 30; Silver Spring, MD.
Cavanagh R, Gritzner S, Dobscha SK, Morasco BJ. Aberrant medication-related behaviors do not differ based on opioid dose: Results from a comprehensive medical record review. Presented at: International Association for the Study of Pain Annual Meeting; 2014 Oct 7; Buenos Aires, Brazil.
Park TW, Friedmann PD. Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders. Rhode Island medical journal. 2014 Oct 1; 97(10):20-4.
Krebs EE. Opioid Risk Mitigation and Adherence Monitoring in Practice. Presented at: National Institutes of Health Office of Disease Prevention Quarterly Workshop; 2014 Sep 30; Bethesda, MD.
Trafton JA. Implementing Guideline Recommendations for Improving the Safety and Effectiveness of Opioid Therapy: Strategies and Lessons Learned From the VHA. Presented at: Conquering Pain Locally, Regionally and Nationally Conference; 2014 Sep 20; Stanford, CA.
Humphreys KN. Damned If We Do... Can We Relieve Pain and Stop Opioid Abuse At the Same Time? Presented at: Conquering Pain Locally, Regionally and Nationally Conference; 2014 Sep 19; Stanford, CA.
Goulet JL, Becker WC, Kerns RD, Justice AC, Fiellin D. Guideline-concordant management of opioid therapy among patients with and without unhealthy alcohol use. Poster session presented at: Research Society on Alcoholism Annual Scientific Meeting; 2014 Jun 21; Bellevue, WA.
Becker WC, Ganoczy D, Fiellin DA, Bohnert AS. Buprenorphine/naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 19; San Juan, Puerto Rico.
Fiellin D, Justice AC. Using the VACS index to track health outcomes associated with abstinence among HIV-infected patients receiving opioid agonist treatment. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 14; San Juan, Puerto Rico.
Justice AC, Goulet JL, Becker WC, Fiellin D. Receipt of opioid therapy guideline-concordant care among HIV-infected and uninfected Veterans. Poster session presented at: College on Problems of Drug Dependence Annual Meeting; 2014 Jun 14; San Juan, Puerto Rico.
Broyles LM. Getting evidence into real-life practice and systems of care: what SBIRT, opioid agonist treatment, and integrated care look like in the VA (Presentation for Advanced Medical Student Fellowship in Alcohol and Other Drug Dependency; Institute for Research, Education and Training in Addictions, Pittsburgh, PA). 2014 Jun 4.
Oliva EM, Konicki PE. Opioid Risk Mitigation and the Role of Naloxone Rescue. Oral presentation (Adobe Connect webinar) to VA SCAN-ECHO (Specialty Care Access Network-Extension for Community Healthcare Outcomes). [Cyberseminar]. 2014 May 27.
Okunseri C, Okunseri E, Xiang Q, Thorpe JM, Szabo A. Prescription of opioid and nonopioid analgesics for dental care in emergency departments: Findings from the National Hospital Ambulatory Medical Care Survey. Journal of public health dentistry. 2014 May 26; 74(4):283-92.
Oliva EM, Burgard J, Drexler K. Overdose Education and Naloxone Distribution (OEND) to Prevent Opioid Overdose. Oral presentation (telephone conference) to the VISN 23 Substance Use Disorder (SUD) Leads. 2014 May 2.
Bachhuber MA, Southern WN, Cunningham CO. Profiting and providing less care: comprehensive services at for-profit, nonprofit, and public opioid treatment programs in the United States. Medical care. 2014 May 1; 52(5):428-34.
Kerns RD, Goulet JL, Dorflinger L, Moore BA. Opioid prescribing and the Stepped Care Model of Pain Management in the Veteran's Health Administration. Poster session presented at: American Pain Society Annual Meeting; 2014 May 1; Tampa, FL.
Becker WC. Recent trends and regional variation in opioid analgesic exposure in the Veterans Health Administration. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2014 Apr 26; San Diego, CA.
Trafton JA, Oliva EM. Overdose Education and Naloxone Distribution (OEND) to Prevent Opioid Overdose. Oral presentation (telephone conference) to the VA Chiefs of Staff. 2014 Mar 27.
Justice AC, Goulet JL, Kerns RD, Fiellin D. Receipt of opioid therapy guideline-concordant care among HIV-infected and uninfected Veterans. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2014 Mar 7; Boston, MA.
Bachhuber MA, Cunningham CO. Changes in testing for human immunodeficiency virus, sexually transmitted infections, and hepatitis C virus in opioid treatment programs. JAMA. 2013 Dec 25; 310(24):2671-2.
Gros DF, De Leo JA, Back SE. Comparing self-report mood-related symptomatology and addiction severity in a sample of prescription opioid dependent and non-dependent individuals. Poster session presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2013 Nov 21; Nashville, TN.
Gros DF, De Leo JA, Back SE, Milanak ME, Brady KT. Comparing clinical profiles of prescription opioid dependent individuals with and without comorbid mood and anxiety disorders. Poster session presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2013 Nov 21; Nashville, TN.
Painter JT, Crofford LJ, Talbert J. Geographic variation of chronic opioid use in fibromyalgia. Poster session presented at: International Society for Pharmacoepidemiology Annual Conference; 2013 Nov 3; Washington, DC.
Bachhuber MA, Cunningham CO. For-profit treatment of opioid addiction. [Letter to the Editor]. Health affairs (Project Hope). 2013 Nov 1; 32(11):2060.
Dobscha SK. Prescription opioids and benzodiazepines: moving beyond "just say no". Pain medicine (Malden, Mass.). 2013 Oct 1; 14(10):1447-9.
Ford AC, Brenner DM, Schoenfeld PS. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis. The American journal of gastroenterology. 2013 Oct 1; 108(10):1566-74; quiz 1575.
Brenner DM, Ford AC, Schoenfeld P. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation, systematic review and meta-analysis. Poster session presented at: Digestive Disease Week Annual Meeting; 2013 May 18; Orlando, FL.
Bair MJ. Prescribing Opioids for Chronic Pain: A Primary Care 'Toolbox' for Employing Rational Analgesia, Managing Risk, and Enhancing Communication. Paper presented at: American College of Physicians Annual Meeting; 2013 Apr 11; San Francisco, CA.
Gordon AJ, Krumm MM. Buprenorphine for opioid dependence. In: Miller PM, editor. Interventions for Addiction: Comprehensive Addictive Behaviors and Disorders. San Diego, CA: Elsevier Inc.; 2013. 417-426 p.
Oliva EM, Trafton JA, Harris AH, Gordon AJ. Trends in opioid agonist therapy in the Veterans Health Administration: is supply keeping up with demand? The American journal of drug and alcohol abuse. 2013 Mar 1; 39(2):103-7.
Painter JT, Crofford LJ. Chronic opioid use in fibromyalgia syndrome: a clinical review. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2013 Mar 1; 19(2):72-7.
Fiellin LE, Tetrault JM, Becker WC, Fiellin DA, Hoff RA. Previous use of alcohol, cigarettes, and marijuana and subsequent abuse of prescription opioids in young adults. The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 2013 Feb 1; 52(2):158-63.
Becker WC, Fiellin DA. Federal plan for prescriber education on opioids misses opportunities. Annals of internal medicine. 2012 Aug 7; 157(3):205-6.
Gordon AJ. An implementation model for addiction pharmacotherapy: buprenorphine for opioid dependence [remote presentation to VISN 21/22 Strategic Planning Meeting FY13: Academic Detailing Pilot on Use of Face to Face Education with Powerful Informatics Tools to Improve Quality of Care, Long Beach, CA]. 2012 Jul 26.
Hausmann LR, Gao S, Lee ES, Kwoh CK. Racial disparities in the monitoring of patients on chronic opioid therapy. Paper presented at: VA HSR&D / QUERI National Meeting; 2012 Jul 17; National Harbor, MD.
Bohnert AS, Blow FC. The association between opioid prescribing patterns and opioid overdose-related deaths. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2012 Jun 12; Palm Springs, CA.
Bohnert AS. Recent non-medical prescription opioid use among adult patients at an inner-city emergency department. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2012 Jun 11; Palm Springs, CA.
Becker WC. Trends in prevalence of non-medical use and prescription opioid abuse/dependence in the U.S., 2000-2009. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2012 May 9; Orlando, FL.
Krebs EE. Barriers to Opioid Monitoring in Primary Care. [Cyberseminar]. 2012 Apr 3.
Skinner MA, Lewis ET, Trafton JA. Opioid use patterns and association with pain severity and mental health functioning in chronic pain patients. Pain medicine (Malden, Mass.). 2012 Apr 1; 13(4):507-17.
Becker WC. Opioids for Chronic Non-Cancer Pain: Knowledge, Skills, and Attitudes. Poster session presented at: Society of General Internal Medicine New England Regional Annual Meeting; 2012 Mar 9; Portland, ME.
Humphreys KN. Public policy on prescription opioids: Are we trapped between Scylla and Charybdis? Invited Plenary. Presented at: American Academy of Pain Medicine Annual Meeting; 2012 Feb 25; Palm Springs, CA.
Sauer BC. Physician specialty and opioid prescribing in the Utah controlled substance database, 2005-2009. [Abstract]. Pain medicine (Malden, Mass.). 2012 Feb 1.
Morasco BJ, Duckart JP, Dobscha SK. Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder. Journal of general internal medicine. 2011 Sep 1; 26(9):965-71.
Price AM, Ilgen MA, Bohnert AS. Prevalence and correlates of nonmedical use of prescription opioids in patients seen in a residential drug and alcohol treatment program. Journal of substance abuse treatment. 2011 Sep 1; 41(2):208-14.
Bohnert AS. Treatment Prior to Opioid Overdose Death. Paper presented at: VA Mental Health Annual Conference; 2011 Aug 24; Baltimore, MD.
Oslin DW. Pharmacogenetics of the mu-opioid receptor for alcohol dependence. Paper presented at: New Clinical Drug Evaluation Unit Annual Meeting; 2011 Jun 13; Fort Lauderdale, FL.
Awosika CO, Sanders SH, Clark ME, Banou E. The Effects of Opioid Use on Veterans with Primary Chronic Headaches Participating in Inpatient Chronic Pain Rehabilitation. Poster session presented at: American Headache Society Annual Meeting; 2011 Jun 4; Washington, DC.
Campbell SR, Matthias MS, Bergman AB, Krebs E. "I feel like I’m not a doctor”: Physicians’ perceptions of opioid management. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2011 May 10; Phoenix, AZ.
Gordon AJ. Opioid dependence in the VA: addressing problems of opioid misuse and dependence through evidence based practice. Paper presented at: U.S. Army Alcohol and Other Drug Use Research Strategic Planning Work Group in Prescription Misuse and Abuse; 2011 May 1; Alexandria, VA.
Trafton JA, Cucciare MA, Lewis E, Oser M. Somatization is associated with non-adherence to opioid prescriptions. The journal of pain : official journal of the American Pain Society. 2011 May 1; 12(5):573-80.
Gordon AJ. Opioid agonist therapy in the VA: trends, barriers, and solutions [symposium]. Presented at: American Society of Addiction Medicine Annual Meeting; 2011 Apr 17; Washington, DC.
Oliva EM, Trafton JA, Sox-Harris A, Gordon AJ. Opioid agonist treatment (OAT) for opioid dependence: Trends in use of buprenorphine and patient and facility factors related to OAT receipt. Paper presented at: VA HSR&D National Meeting; 2011 Feb 18; National Harbor, MD.
Morasco BJ, Duckart J, Dobscha SK. Adherence to Clinical Guidelines for the Use of Chronic Opioid Therapy in Veterans with Chronic Pain Based on Substance Use Disorder Status. Poster session presented at: VA HSR&D National Meeting; 2011 Feb 15; National Harbor, MD.
Broyles LM, Hanusa BH, Krumm M, Paidisetty S, Forman SD. Comparative outcomes of VA office-based buprenorphine and methadone treatment for opioid dependence in the VA. Paper presented at: VA Implementing a Public Health Model for Meeting the Mental Health Needs of Veterans Annual Mental Health Conference; 2010 Jul 28; Baltimore, MD.
Oliva EM, Trafton JA, Harris AH, Gordon AJ. Trends in Use of Buprenorphine for the Treatment of Opioid Dependence. Paper presented at: VA Implementing a Public Health Model for Meeting the Mental Health Needs of Veterans Annual Mental Health Conference; 2010 Jul 27; Baltimore, MD.
Goulet JL. Non-medical use of prescription opioids among Veterans with and without HIV: Pain, psychiatric, medical and substance use correlates. Paper presented at: College on Problems of Drug Dependence Annual Meeting; 2010 Jun 20; Reno, NV.
Lewis ET, Combs A, Trafton JA. Reasons for under-use of prescribed opioid medications by patients in pain. Pain medicine (Malden, Mass.). 2010 Jun 1; 11(6):861-71.
Oser ML, Cucciare MA, Trafton JA. Impact of Somatization on the misuse of prescription opioids. Poster session presented at: Society of Behavioral Medicine Annual Meeting and Scientific Sessions; 2010 Apr 8; Seattle, WA.
Tuteja AK, Biskupiak J, Stoddard GJ, Lipman AG. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterology and Motility : The Official Journal of The European Gastrointestinal Motility Society. 2010 Apr 1; 22(4):424-30, e96.
Sauer BC. Adult Use of Prescription Opioid Pain Medications—Utah, 2008. JAMA. 2010 Jan 1; 303(14):1359-1361.
Dosa DM, Dore DD, Mor V, Teno JM. Frequency of long-acting opioid analgesic initiation in opioid-naïve nursing home residents. Journal of pain and symptom management. 2009 Oct 1; 38(4):515-21.
Trafton JA. Decision support for the management of opioid therapy in chronic pain. [Cyberseminar]. 2009 Sep 23.
Lewis E, Trafton JA. Resisting opioid therapy: Strategies patients use with health care providers. Paper presented at: American Sociological Association Annual Meeting; 2009 Aug 8; San Francisco, CA.
Broyles LM, Paidisetty S, Forman SD, Krumm MM, Gordon AJ. Buprenorphine and methadone opioid agonist therapy: differences in patient enrollment characteristics within a VA medical center. Poster session presented at: VA MIRECC Annual Best Practices in Mental Health Conference; 2009 Jul 21; Washington, DC.
Phillips KA, Walley AY, Gordon AJ. Patients in recovery (PIR): success at teaching opioid addiction treatments to physicians. Poster session presented at: Association for Medical Education and Research in Substance Abuse Annual Meeting; 2008 Nov 6; Washington, DC.
Roth CS, Burgess DJ. Changing residents' beliefs and concerns about treating chronic noncancer pain with opioids: evaluation of a pilot workshop. Pain medicine (Malden, Mass.). 2008 Oct 1; 9(7):890-902.
Friedly J, Nishio I, Bishop MJ, Maynard C. The relationship between repeated epidural steroid injections and subsequent opioid use and lumbar surgery. Archives of physical medicine and rehabilitation. 2008 Jun 1; 89(6):1011-5.
Trafton JA. Improving Delivery of Evidence-Based Opioid Therapy: The ATHENA-Opioid Decision Support System. Paper presented at: American Pain Society Annual Meeting; 2008 May 9; Tampa, FL.
Bair MJ. Opioids for Chronic Pain, Chronic Disease Care and Management. Paper presented at: Society of General Internal Medicine Annual Meeting; 2008 Apr 9; Pittsburgh, PA.
Grosheider T, Luther J, Ramgopal R, Gordon AJ. Physician attitudes toward harm reduction in office-based opioid agonist therapy. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2008 Apr 9; Pittsburgh, PA.
Phillips K, Gordon AJ, Walley AY. Patients in recovery and opioids. Paper presented at: Society of General Internal Medicine Annual Meeting; 2008 Apr 9; Pittsburgh, PA.
Trafton JA, Tracy SW, Oliva EM, Humphreys K. Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems. Journal of Studies On Alcohol. 2007 Mar 1; 68(2):165-72.
Roth CS, Burgess DJ, Mahowald ML. Medical residents' beliefs and concerns about using opioids to treat chronic cancer and noncancer pain: a pilot study. Journal of rehabilitation research and development. 2007 Jan 1; 44(2):263-70.
Stein MD, Friedmann PD. Optimizing opioid detoxification: rearranging deck chairs on the Titanic. Journal of addictive diseases. 2007 Jan 1; 26(2):1-2.
Pletcher MJ, Kertesz SG, Sidney S, Kiefe CI, Hulley SB. Incidence and antecedents of nonmedical prescription opioid use in four US communities. The Coronary Artery Risk Development in Young Adults (CARDIA) prospective cohort study. Drug and Alcohol Dependence. 2006 Nov 8; 85(2):171-6.
Carey T, Krebs E. Review: opioids are more effective than placebo but not other analgesics for chronic noncancer pain. ACP journal club. 2006 Nov 1; 145(3):74.
Trafton JA, Minkel J, Humphreys K. Opioid substitution treatment reduces substance use equivalently in patients with and without posttraumatic stress disorder. Journal of Studies On Alcohol. 2006 Mar 1; 67(2):228-35.
Edlund MJ, Sullivan M, Steffick D, Harris K. Do Users of Regularly Prescribed Opioids Have Higher Rates of Substance Abuse Problems than Non-Users? Poster session presented at: Addiction Health Services Research Conference; 2005 Oct 26; Santa Monica, CA.
Humphreys K, Trafton JA, Oliva E. Does following practice guidelines matter in the real world of heroin dependence treatment: Multisite Opioid Substitution Treatment Study. Paper presented at: VA HSR&D National Meeting; 2005 Jun 26; Boston, MA.
Trafton JA, Minkel JD, Humphreys K. Posttraumatic stress disorder does not impair substance use disorder outcomes in opioid substitution treatment. Paper presented at: VA HSR&D National Meeting; 2005 Jun 26; Boston, MA.
Trafton JA, Basbaum AI. [d-Ala2,N-MePhe4,Gly-ol5]enkephalin-induced internalization of the micro opioid receptor in the spinal cord of morphine tolerant rats. Neuroscience. 2004 Apr 1; 125(3):541-3.
Trafton J, Oliva E, Horst DA, Minkel JD, Humphreys KN. Clinical practices and outcomes in opioid substitution programs: 6-month outcomes. Meeting the changing needs of veterans: the quality/cost equation. Paper presented at: VA HSR&D National Meeting; 2004 Mar 2; Washington, DC.
Willenbring ML, Hagedorn H. Implementing evidence-based practices in opioid agonist clinics. In: Roberts AR, Yeager KR, editors. Evidence-Based Practice Manual: Research and Outcome Measures in Health and Human Services. New York, NY: Oxford University Press; 2004. Chapter 35. 340-347 p.
DeMarco F, Calsyn D, Saxon A, Sloan K, Gibbon K. Alternatives to discharge: Two-year outcomes of a 'minimal services' program for non-compliant opioid substitution clients. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine. 2001 Sep 15; 23:S153.
DeMarco F, Calsyn D, Saxon A, Sloan K, Gibbon K. Evaluation of a 'minimal services' treatment track as an alternative to discharge for non-compliant patients in opioid substitution treatment. Drug and Alcohol Dependence. 2000 Oct 15; 60:S30.